Dr. Gary Lemack, MD
What this data tells you about Dr. Lemack
Dr. Gary Lemack is an urology physician in Dallas, TX, with 20 years in practice. Based on federal Medicare data, Dr. Lemack performed 35,541 Medicare services across 1,964 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lemack received a total of $96,626 from 31 pharmaceutical and/or device companies across 288 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lemack is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit | 30,000 | $5 | $16 |
| BCG treatment for bladder cancer | 3,280 | $2 | $10 |
| Urinalysis, manual | 511 | $3 | $18 |
| Office visit, established patient (30-39 min) | 323 | $86 | $344 |
| Office visit, established patient (20-29 min) | 241 | $59 | $232 |
| Bladder ultrasound after voiding | 235 | $8 | $80 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 172 | $295 | $1,206 |
| New patient office visit (45-59 min) | 98 | $119 | $533 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 97 | $22 | $698 |
| Simple change of bladder tube | 77 | $67 | $448 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 73 | $250 | $1,118 |
| Insertion of device into abdomen with pressure and urine flow rate study | 73 | $134 | $697 |
| Instillation of anti-cancer drug into bladder | 71 | $65 | $468 |
| Diagnostic exam of bladder and urethra using an endoscope | 64 | $176 | $837 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 63 | $131 | $2,030 |
| Complex measurement of pressure of urine flow in bladder | 28 | $204 | $1,229 |
| Simple insertion of temporary bladder tube | 26 | $46 | $309 |
| New patient office visit (30-44 min) | 22 | $80 | $347 |
| Simple bladder irrigation and/or instillation | 17 | $54 | $346 |
| Office visit, established patient (10-19 min) | 16 | $36 | $140 |
| Office visit, established patient, complex (40-54 min) | 16 | $106 | $464 |
| Injection procedure for imaging of bladder during voiding | 14 | $88 | $850 |
| Aspiration of bladder with insertion of bladder tube to skin | 12 | $87 | $1,005 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 12 | $24 | $143 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (76%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for urology physician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lemack is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (consulting-driven, top 4%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lemack experienced with botox injection, per unit?
Does Dr. Lemack receive payments from pharmaceutical companies?
How do Dr. Lemack's costs compare to other urology physicians in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology